See also this year's filing and all EDGAR filings for this company.
PDF Report 0001733413_2023_TFF_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001733413, TFF Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 19,025,166 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,078,342 |
| 3 | remainder_Assets | 2,016,707 |
| 4 | LiabilitiesCurrent | 1,130,662 |
| 5 | LiabilitiesNoncurrent | 110,094 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,796,255 |
| 9 | ResearchAndDevelopmentExpense | 18,496,340 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 495,805 |
| 12 | remainder_NetIncome | 26,728 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 24,120,215 |
| 1 | Liabilities | 1,240,756 |
| 2 | Expenses | 32,292,595 |
| 3 | Revenues | 495,805 |
| 4 | StockholdersEquity | 22,879,459 |
| 5 | NetIncome | -31,770,062 |
| 6 | ComprehensiveNetIncome | -31,770,062 |
| 7 | BaseVar | 29,088,050 |
| 8 | EconomicCapitalRatio | 0.598 |
Edgar->Model Mapping
Feature Distribution
Change over Time
